Most people have heard of breast cancer as a single disease. It is not. Where the cancer starts inside the breast changes how it grows, how it shows up on imaging, what symptoms it causes, and sometimes how it is treated. Lobular and ductal carcinoma are the two most common types. Knowing the difference matters because one of them is notoriously easy to miss on a standard mammogram.

According to Dr. Garvit Chitkara, a leading Breast Cancer Surgeon in Mumbai,
“Ductal carcinoma is what most people picture when they think of breast cancer. It forms a distinct mass, shows up clearly on imaging, and follows a fairly predictable pattern. Lobular carcinoma is different. It spreads in single file lines through the breast tissue without forming a clear lump. Women can have a significant lobular tumour and feel nothing. That is why it gets diagnosed later on average, and why MRI is much more valuable in suspected lobular disease.”

What is ductal carcinoma and how does it present?

Ductal carcinoma starts in the milk ducts and accounts for roughly 70 to 80 percent of all breast cancers. It is the most studied and most recognised type:

  • Forms a distinct mass. Ductal tumours typically grow as a defined lump that can be felt on examination or seen clearly on mammogram and ultrasound. This makes detection more straightforward compared to lobular disease.
  • Microcalcifications are a key finding. Early ductal carcinoma in situ (DCIS) often shows up as microcalcifications on mammography before any mass is palpable. This is one reason routine mammography screening catches many ductal cancers early.
  • Wide range of grades. Ductal carcinomas range from low-grade, slow-growing tumours to high-grade aggressive ones. Grade influences treatment decisions alongside subtype and stage.
  • Responds to standard treatment protocols. Surgery, radiation, chemotherapy, hormone therapy, and targeted therapy are all used depending on subtype and stage. Treatment pathways are well established.

Both lobular and ductal carcinomas require surgical management tailored to the individual case. The breast cancer surgery page covers the full range of surgical options available.

Could the type of breast cancer you have influence how it is detected and treated?

What is lobular carcinoma and why is it harder to detect?

Lobular carcinoma starts in the milk-producing lobules. It accounts for around 10 to 15 percent of invasive breast cancers and has several features that make it clinically distinct:

  • No classic lump. Lobular cancer cells spread in single file lines through the breast without forming a cohesive mass. Women often notice a thickening or fullness rather than a defined lump. Many notice nothing at all until imaging picks it up.
  • Frequently missed on mammogram. Because lobular carcinoma does not form a discrete mass or calcifications, standard mammography misses it more often than it misses ductal cancer. MRI is significantly more sensitive and is often recommended when lobular carcinoma is suspected.
  • Higher rate of bilateral disease. Lobular carcinoma has a greater tendency to occur in both breasts, either simultaneously or at different times. This influences surgical planning and follow-up strategy.
  • Spreads to unusual sites. When lobular carcinoma metastasises, it tends to spread to locations less typical of ductal carcinoma, including the gastrointestinal tract, ovaries, and meninges, which can make metastatic presentations harder to connect back to the primary breast cancer.

For a detailed look at how ductal carcinoma behaves at a more advanced stage, the invasive ductal carcinoma blog covers stage 3 disease specifically.

Why Choose Dr Garvit Chitkara ?

Dr. Garvit Chitkara is Associate Director of Breast Surgical Oncology and Oncoplasty at Nanavati Max Institute of Cancer Care, Mumbai, with 17 years of experience in breast surgical oncology. He manages both lobular and ductal carcinomas within a multidisciplinary framework, tailoring surgical and systemic treatment to the specific tumour type. 

FAQ

Is lobular carcinoma more dangerous than ductal carcinoma?

Not necessarily. Lobular carcinoma is often diagnosed at a later stage because it is harder to detect, which affects outcomes. When caught at the same stage, survival rates are broadly comparable.

Can lobular carcinoma be treated with lumpectomy?

Yes, in many cases. Because lobular tumours can be diffuse, margins can be harder to achieve, and mastectomy is sometimes chosen. Each case is assessed individually based on imaging and tumour extent.

Does lobular carcinoma show up on a mammogram?

 It can, but mammography misses lobular carcinoma more often than ductal carcinoma. MRI is significantly more sensitive and is commonly used when lobular disease is confirmed or suspected.

Are lobular and ductal carcinoma treated the same way?

Broadly yes, with surgery, radiation, and systemic therapy based on subtype and stage. Lobular carcinoma is almost always HR positive, which means hormone therapy plays a central role in its treatment.

Disclaimer: This blog is for educational purposes only; the diagnosis, behaviour, and treatment of lobular and ductal breast cancer vary between individuals and should be discussed with a qualified breast cancer specialist.

Call Now Button